| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |